SKI Market

Indian Indices

Nifty

25,114.00 108.50
(0.43%)

Sensex

81,823.03 -81.67
( -0.10%)

Bank Nifty

54,809.30 139.70
( 0.26%)

Nifty IT

36,110.75 107.30
( 0.30%)

Global Indices

Nasdaq

45,857.35 271.66
(-0.59%)

Dow Jones

6,605.38 -3.09
(-0.05%)

Hang Seng

44,778.02 405.52
(0.91%)

Nikkei 225

9,283.29 -14.29
(-0.15%)

Forex

USD-INR

88.28 0.18
(0.20%)

EUR-INR

103.39 0.27
(0.26%)

GBP-INR

119.55 0.32
(0.27%)

JPY-INR

0.60 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

397.3891536

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

24.61

127124.34

EPS(TTM)

Face Value()

Div & Yield %

63.96

1.02

Back

Suraj consolidated net profit declines 51.93% in the June 2025 quarter

Jul 29,2025

Net profit of Suraj declined 51.93% to Rs 2.74 crore in the quarter ended June 2025 as against Rs 5.70 crore during the previous quarter ended June 2024. Sales declined 8.04% to Rs 50.34 crore in the quarter ended June 2025 as against Rs 54.74 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	50.34	54.74	-8
OPM %	9.61	16.48	-
PBDT	6.20	10.28	-40
PBT	3.37	7.57	-55
NP	2.74	5.70	-52

25,114.00 108.50 (0.43%)

81,823.03 -81.67 ( -0.10%)

54,809.30 139.70 ( 0.26%)

36,110.75 107.30 ( 0.30%)

45,857.35 271.66 (-0.59%)

6,605.38 -3.09 (-0.05%)

44,778.02 405.52 (0.91%)

9,283.29 -14.29 (-0.15%)

88.28 0.18 (0.20%)

103.39 0.27 (0.26%)

119.55 0.32 (0.27%)

0.60 0.00 (0.17%)